Novo Nordisk Denmark A/S — Credit Rating and Financial Key Figures

Novo Nordisk Denmark A/S (CVR number: 38180045) is a company from KØBENHAVN. The company reported a net sales of 2367.8 mDKK in 2024, demonstrating a growth of 17.4 % compared to the previous year. The operating profit percentage was at 4.3 % (EBIT: 101.4 mDKK), while net earnings were 86.1 mDKK. The profitability of the company measured by Return on Assets (ROA) was 10.6 %, which can be considered good but Return on Equity (ROE) was 86.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 9.6 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. Novo Nordisk Denmark A/S's liquidity measured by quick ratio was 1.1 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.